Page last updated: 2024-09-03

dx 9065a and cholestyramine resin

dx 9065a has been researched along with cholestyramine resin in 1 studies

Compound Research Comparison

Studies (dx 9065a)	Trials (dx 9065a)	Recent Studies (post-2010) (dx 9065a)	Studies (cholestyramine resin)	Trials (cholestyramine resin)	Recent Studies (post-2010) (cholestyramine resin)
92	7	8	2,669	342	190

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akashi, M; Fujii, Y; Kanamaru, T; Kikuchi, H; Nakagami, H; Sakuma, S; Yamashita, S	1

Trials

1 trial(s) available for dx 9065a and cholestyramine resin

Article	Year
Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form. International journal of pharmaceutics, 2011, Dec-15, Volume: 421, Issue:2 Topics: Administration, Oral; Adult; Animals; Anticoagulants; Bile Acids and Salts; Biological Availability; Cholestyramine Resin; Cross-Over Studies; Dosage Forms; Factor Xa Inhibitors; Female; Haplorhini; Humans; Ion Exchange Resins; Macaca fascicularis; Nanospheres; Naphthalenes; Polymers; Propionates; Rats; Rats, Sprague-Dawley; Young Adult	2011

Article

Year

Improvement of low bioavailability of a novel factor Xa inhibitor through formulation of cationic additives in its oral dosage form.

International journal of pharmaceutics, 2011, Dec-15, Volume: 421, Issue:2

Topics: Administration, Oral; Adult; Animals; Anticoagulants; Bile Acids and Salts; Biological Availability; Cholestyramine Resin; Cross-Over Studies; Dosage Forms; Factor Xa Inhibitors; Female; Haplorhini; Humans; Ion Exchange Resins; Macaca fascicularis; Nanospheres; Naphthalenes; Polymers; Propionates; Rats; Rats, Sprague-Dawley; Young Adult

2011